Knight Therapeutics | GUD - 贷款资金

股票价格

7.55

每天变化

-0.10 -1.31%

每月一次

21.97%

每年

35.06%

Q2 预测

7.37

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 771.93M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	贷款资金	更改		日
Acasti Pharma	USD 0		0	2024-12
Akebia Therapeutics	USD 48.25M		609K	2025-12
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
Aurora Cannabis	CAD 33.2M		1.79M	2025-12
Avita Medical	AUD 42.24M		1.25M	2024-12
Canopy Growth	CAD 224.99M		1.34M	2025-12
Dianthus Therapeutics	USD 0		0	2024-12
Ionis Pharmaceuticals	USD 1.9B		1.87B	2025-12
IQVIA Holdings	USD 13.88B		1.09B	2025-12
Knight Therapeutics	CAD 57.78M		26.92M	2025-12
Moderna	USD 610M		584M	2025-12
Omeros	USD 403.72M		27.2M	2024-06
Organigram Holdings	CAD 62.52M		13.88M	2025-12
Organon & Co	USD 8.78B		117M	2025-09
Revvity	USD 2.63B		543K	2025-12
Tectonic Therapeutic	USD 43K		57K	2025-12
Tilray	USD 268.59M		3.82M	2025-09
Viatris	USD 12.48B		7M	2025-12
Xeris Pharmaceuticals	USD 220.33M		866K	2025-12